FDA approves Bristol-Myers breast cancer drug (Reuters)


A new chemotherapy drug called
Ixempra made by Bristol-Myers Squibb Co for women with advanced
breast cancer
that does not respond to other therapies has won
U.S. approval to be sold and is expected to be available in
days.